AIM
CVRS

Acrospire Investment Management’s CORINDUS VASCULAR ROBOTICS, INC CVRS Stock Holding History

Acrospire Investment Management’s Portfolio CVRS Stock Details CVRS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-2,018
Closed -$4K – 1850
2017
Q2 		$4K Buy
+2,018
New +$2.69K ﹤0.01% 2006

Other funds holding CVRS

HM
HealthCor Management New York $109M AUM 10.64% 1-Year Est. Return
CCM
Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return
HEC
Hudson Executive Capital New York $151M AUM 60.14% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
EIM
Essex Investment Management Boston, Massachusetts $632M AUM 95.36% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Acrospire Investment Management's CVRS Position: Q3 2017 in Review

Acrospire Investment Management sold out of CORINDUS VASCULAR ROBOTICS, INC (CVRS) in Q3 2017, closing a stake of 2,018 shares — an estimated $4K sold.

Acrospire Investment Management first reported a position in CVRS in Q2 2017 and held it in 1 quarter. The position peaked at $4K in Q2 2017. 58 funds tracked by Wall St. Rank hold CVRS as of Q3 2017.

  • Acrospire Investment Management reported no remaining CORINDUS VASCULAR ROBOTICS, INC position as of Q3 2017 after selling out during the quarter.
  • Acrospire Investment Management sold 2,018 CORINDUS VASCULAR ROBOTICS, INC shares in Q3 2017, an estimated $4K.
  • Acrospire Investment Management first reported a position in CORINDUS VASCULAR ROBOTICS, INC in Q2 2017 and held it in 1 quarter.
  • Acrospire Investment Management's CORINDUS VASCULAR ROBOTICS, INC position peaked at $4K in Q2 2017.
  • 58 funds tracked by Wall St. Rank held CORINDUS VASCULAR ROBOTICS, INC as of Q3 2017.

Based on Acrospire Investment Management's 13F filing for Q3 2017, filed 26 Oct 2017.